Arkolith/Insider Trading/EPZM/Form 4

Beaulieu Joseph

See RemarksEpizyme, Inc. (EPZM) · full profile →Form 4 · filed Mar 21, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 28, 2022Grant(A)2K$1.27$3K31K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 17, 2022Grant(A)300K—$0300K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-011728) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML